: iStockAnalyst.com Symbols Feed

Celgene (NASDAQ:CELG): Selloff Opportunity

Mon, 06 Apr 2009 16:46:11 GMT

After warning that Celgene (NASDAQ: CELG) would only achieve the low end of its previous guidance range for 2009, the stock of the company sold off significantly, noted biotech expert John McCamant.[More...]

Celgene (CELG): Strong Growth In Biotech

Fri, 20 Feb 2009 14:31:00 GMT

"Celgene (NASDAQ: CELG) reported their fourth quarter and year end numbers which showed strong revenue growth." observes biotech sector expert John McCamant. The editor of The Medical Technology Stock Letter explains, "We remain excited about CELG’s growth prospects and[More...]

CBO Projects $1.2 Trillion Deficit for 2009

Wed, 07 Jan 2009 18:54:00 GMT

I think it's gotten to the point that people are getting immune to the large numbers thrown around. The Federal Reserve is backstopping or supporting $8.5 Trillion of markets. We hand the banks $700 Billion. We have another stimulus coming of $800 Billion. We gave out $160 Billion last spring as "stimulus". At some points these numbers matter - this grand experiment of pumping up a debt laden society by.... more debt.... is frankly scary. The largest federal deficit we ever ran was $400 Billion-ish. The punditry has been saying this year we will hit $1 Trillion in fiscal 2009. Today the Congressional Budget[More...]

New York Times: As Vacant Office Space Grows, So Does Lenders' Crisis

Tue, 06 Jan 2009 17:54:00 GMT

Normally I'd be worried about this type of story and offer dire warnings that I've been repeating for a long time. I'd fill you with holiday cheer about how retail outlets you know will go bankrupt, one off mom and pop shops you never heard of would go under, and strip malls across Americana will be sitting 30-70% empty in about 12-15 months. How shrinking small businesses who once sat in office building suites will go under and leave half empty floors in building across building. However, President Elect Midas shall magically fill 80% of all empty office space by transforming a nation of service workers into shovel diggers and Caterpillar machine workers. (and solar panel installers and school retrofitters - whatever that is) How that fills office space, I[More...]

9 ( Nine ) For 09 , Risky Stock Picks ( 2009 )

Fri, 02 Jan 2009 03:26:00 GMT

1. Midas ( MDS ) 10.49 a share As of 1/1/2009 Midas, Inc. is a provider of automotive repair and maintenance services with over 2,550 shops globally. Midas retail shops, which are operated by the Company, its franchisees and licensees, offer an array of automotive repair and maintenance services. As of December 29, 2007, there were 1,711 North American Midas shops located in all 50 United States and nine[More...]

American Science & Engineering - Very Promising

Wed, 31 Dec 2008 14:00:00 GMT

Speaking of solid defense type companies with heavy reliance on the most lucrative customer ever know to man (the U.S. federal government) we have a stock which has had a very nice year - American Science & Engineering (ASEI). American Science and Engineering, Inc. (AS&E) is the leading worldwide supplier of innovative X-ray inspection systems. With 50 years of experience in developing advanced X-ray security systems, the Company’s product line utilizes a[More...]

Best Performing Stock of 2008

Mon, 29 Dec 2008 13:58:00 GMT

I used to, and will one day return, to posting the best performing stocks of the week - but the wicked volatility and "student body left" trading of the past 4 months has made it a moot point. Everything must either be bought or sold, as stocks are either deemed "good" or "bad" that hour, day, or month. The herd piles in, or piles out - regardless of sector, style, fundamentals. It's been a market of asset allocation not individual stocks much of the back half of the year. I like to look for relative strength and ride sector/company trends for the longer term - this market is not for that sort of investor. This has been for many months a run and gun daytrader environment; not a place for theme investors. With that said, I am always curious to see what stocks held up over the long run... folks, no matter what happens (short of 8%+ rally here in the next 3 days) we are projecting the worst year in the markets at least since the[More...]

Market Commentary: 12/22/08

Mon, 22 Dec 2008 19:14:00 GMT

Fratricide? Patricide? Genocide? Investicide Somewhere among the moneyed elite, you may have heard the following conversations: “I hear you[More...]

BusinessWeek: Clouds Over the Solar Industry

Sun, 21 Dec 2008 08:09:00 GMT

Unfortunately, the shakeout that I theorized would happen in the solar field is appearing to happen much earlier than I anticipated (Jan 3: The Long Term in Solar) due to credit crunch and global economic slowdown/recession. A lot of failures and consolidation should occur - keep in mind for every 1 Chinese solar stock trading on an exchange, about 9 (last I checked) are private in either Hong Kong or China. With capital intensive process and capital intensive needs of customer for projects it's not the greatest of times as BusinessWeek points out. Looking at the stocks,[More...]

Gold Short Squeeze Warning: Comex Brokers

Sun, 14 Dec 2008 17:52:00 GMT

Gold Short Squeeze Warning: Comex Brokers Very interesting letter from our friend Chris Powell at GATA. If this rumor is true, it could have some serious ramifications to the short term gold price. GATA’s Bill Murphy reports that this is a “highly unusual” situation. *** Comex said warning brokers about December gold squeeze Submitted by cpowell on Sat, 2008-12-13 04:11. Section: Daily Dispatches From “Midas” Commentary by Bill Murphy LeMetropoleCafe.com Friday, December 12, 2008 I received a call this morning from a commodities broker who told me that the Comex is alerting various futures firms about the potential of a squeeze on the December contract and is advising the $840 December shorts to exit their positions. That is the remaining open position. There have been 12,636[More...]

MDS Announces Voting Support Agreements

Wed, 02 Sep 2009 13:04:00 GMT

TORONTO, Sept. 2 /CNW/ - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets earlier today disclosed that it had entered into an agreement to sell its MDS Analytical Technologies business to Danaher Corporation (NYSE: DHR) for $650 million in cash. Further to this announcement, ValueAct Capital and Enterprise Capital Management Inc., two of the Company's largest shareholders, who collectively own approximately 23% of the Company's outstanding common shares, have each entered into an agreement with Danaher pursuant to which they have agreed to vote their common shares in favor of the transaction. These agreements are subject to the ability of the shareholders to change their vote ...[More...]

11 Midas Shops in San Diego Area Add SpeeDee Oil Change Services

Wed, 26 Aug 2009 14:46:00 GMT

Midas, Inc. (NYSE: MDS) has brought the well-known Northern California SpeeDee Oil Change name to San Diego by adding SpeeDee quick-lube services to 11 company-owned Midas shops in the San Diego market.
SpeeDee specializes in convenient high-quality oil changes and fluid service, while Midas is known for its full range of automotive repair and maintenance offerings.
"Midas has performed oil changes for many years, but at many shops in the past customers were asked to make appointments or leave their cars and we would perform the oil change when we had an open bay," said William M. Guzik, Midas' executive vice president.

[More...]

Midas Reports Second Quarter Earnings of $0.03 Per Diluted Share after $0.09 of Non-Cash Special Items; 11 Percent Increase in Traffic at U.S. Midas Shops Offset by Decline in Average Ticket; SpeeDee Co-Brand Test Shops Post 17 Percent Sales Increase

Thu, 06 Aug 2009 12:10:00 GMT

Midas, Inc. (NYSE: MDS) reported net earnings of $0.4 million—or $0.03 per diluted share for the second quarter ended July 4, 2009, compared to $2.2 million—or $0.16 per diluted share—in the second quarter of 2008. The second quarter 2009 results include $0.09 of non-cash special items, primarily related to the vesting of restricted stock issued in 2005 and 2006. These non-cash special items resulted in approximately $0.7 million of administrative expense and $0.8 million of additional income tax expense, which drove the effective tax rate to 78.6 percent for the quarter.[More...]

MDS Nordion Submits Expression of Interest Proposal to Government of Canada on Medical Isotope and Generator Production

Thu, 30 Jul 2009 13:55:00 GMT

MAPLE Reactors Could Solve the Isotope Crisis within 24 months OTTAWA, July 30 /CNW/ - MDS Nordion, a leading provider of medical isotopes and radiopharmaceuticals, has submitted a Proposal to the Government of Canada's Expert Review Panel on Medical Isotope and Technetium-99m (Tc-99m) Generator Production. MDS Nordion believes that the best answer to the shortage of medical radioisotopes is the completion and bringing into service of the MAPLE project. The MDS Nordion Proposal outlines technical and regulatory requirements needed for the provision of a secure supply of medical isotopes for the health care system in Canada and around the world.[More...]

MDS Nordion Continues to Urge Government of Canada to Complete MAPLE Project to Address Critical Medical Isotope Shortage

Wed, 08 Jul 2009 16:18:00 GMT

Experts Believe MAPLE Reactors Can Be Brought Into Service[More...]

MDS Inc. Completes Divestiture of MDS Pharma Services Phase II-IV Operations

Wed, 01 Jul 2009 11:55:00 GMT

MDS Pharma Services to Focus on the Delivery of Early Stage Services - Discovery Through Phase IIa TORONTO, July 1 /CNW/ - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today announced that it has completed the divestiture of its Phase II-IV operations to INC Research,(R) Inc.[More...]

MDS Nordion Collaborates With Karpov Institute of Physical Chemistry to Develop Molybdenum-99 for Global Nuclear Medicine Market

Mon, 15 Jun 2009 11:55:00 GMT

New Partnership Seeks to Strengthen Fragile Medical Isotope Supply Chain OTTAWA, June 15 /CNW/ - MDS Nordion, a leading global provider of medical isotopes and radiopharmaceuticals used in molecular medicine, today announced that the Company and the Karpov Institute of Physical Chemistry in Moscow, Russia, have agreed to study the feasibility of the Karpov Institute providing the Company with a viable and reliable supply of Molybdenum-99 (Mo-99) for the global nuclear medicine market.[More...]

Midas Reaches out to Displaced Service Customers, Dealers and Employees of Closing Auto Dealerships

Thu, 11 Jun 2009 19:22:00 GMT

Midas, Inc. (NYSE: MDS), which franchises and operates more than 1,650 Midas automotive service centers in North America, is launching a comprehensive effort aimed at service customers, dealers and employees of automotive dealerships that are closing.[More...]

MDS Nordion Begins to Manufacture Cardiac Imaging Agent

Wed, 10 Jun 2009 11:55:00 GMT

Bracco's Cardiogen-82(R) Enables Cardiologists to Better Detect Cardiovascular Disease OTTAWA, June 10 /CNW/ - MDS Nordion, a leading provider of medical isotopes and radiopharmaceuticals, today announced that it has commenced the manufacture of CardioGen-82(R) (Rubidium-82 generators), for Bracco Diagnostics, Inc. (part of Bracco Group), one of the world's leading companies in the imaging agent business.[More...]